Diligence memo · auto-generated · as of July 2, 2026
Base5 Genomics, Inc.
Base5 Genomics, Inc. has raised $5.3M over 2 rounds; too few niche peers to rank its valuation yet.
Businessfiled
Base5 Genomics, Inc. operates in Biotech, based in PALO ALTO.
Sub-sector tags: biotech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Base5 Genomics, Inc. has raised $5.3M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $4.2M on 2021-09-09.
Most recent recorded round closed around 2021-09-09.
Valuation (modeled)modeled
Provath models Base5 Genomics, Inc. at approximately $86M (range $4.6M–$354M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 16 months.
Last raise 4.8 yr ago; this sector typically re-raises about every 11 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 4.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 81% of Biotech peers (233 compared).
Modeled value ranks above 86% of those peers.
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.